Research Article

FBXW7 Reduces the Cancer Stem Cell-Like Properties of Hepatocellular Carcinoma by Regulating the Ubiquitination and Degradation of ACTL6A

Figure 3

FBXW7 inhibits the tumorigenesis in vivo and interferes with sorafenib resistance of HCC cells. (a) Images of xenografts in nude mice 6 weeks after subcutaneous injection of indicated cells. (b, c) Xenograft tumors growth curve and weight. Tumor volume was calculated by . (d) IHC staining of FBXW7 and pluripotency-associated markers in respective xenograft tumor tissues. (e) FBXW7 overexpression increased the sensitivity to sorafenib, while FBXW7 knockdown reduced the sensitivity to sorafenib. (f) The influence of FBXW7 or sorafenib on the sphere formation in MHCC-97H or Huh7 cells. Graph represents ; , , .
(a)
(b)
(c)
(d)
(e)
(f)